This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Ankylosing Spondylitis, Cervicothoracic Region강직척추염, 경흉추부

ICD-10M45.3
Synonyms / related termsAnkylosing spondylitis with cervicothoracic junction involvement, CTJ AS, C7-T1 ankylosing spondylitis
Special Copayment ReductionV140 — Severe intractable disease (copayment 10%, 5 years)
Main age of onsetOnset at ages 15-35; cervicothoracic junction involvement appears during the course of cervical and thoracic involvement

Contents

s1History
s2Causes
s3Genetics
s4General epidemiology
s5Pathophysiology
s6Symptoms
s7Signs
s8Screening
s9Diagnosis
s10Treatment
s11Prognosis
s12Prevention
s13References

1. History

Involvement of the cervicothoracic junction (CTJ, C7-T1 and adjacent segments) in ankylosing spondylitis (AS) is a special site that clinically shows the combined characteristics of cervical and thoracic involvement. The cervicothoracic junction is a site where mechanical stress is concentrated between the highly mobile cervical spine and the thoracic spine fixed by the chest wall, and degenerative changes are common here even in the non-AS population. In the history of AS, this site was described together with cervical and thoracic involvement as radiographic studies progressed in the 1970s-80s. Advances in CT and MRI made it possible to accurately assess bony fusion, discitis, and syndesmophytes of the cervicothoracic junction. Fractures at this site are sometimes difficult to detect on radiographs, so CT is essential. Spinal cord injury after an AS-related fracture of the cervicothoracic junction, especially upper thoracic spinal cord injury, is a serious complication causing incomplete quadriplegia. A multidisciplinary approach (rheumatology, neurosurgery, anesthesiology) is especially important in managing involvement of this site.

2. Causes

The causes of cervicothoracic AS involve a combination of risk factors for systemic AS (HLA-B27 positivity, long disease duration, inadequate treatment, smoking) and the mechanical particularities of this site (the transition from the mobile cervical spine to the fixed thoracic spine). The cervicothoracic junction is where the orientation of the facet joints changes (horizontal → coronal plane) in the transition from cervical to thoracic spine and where thoracic fixation by rib attachment begins, so repetitive mechanical loading is concentrated on the ligament and joint capsule entheses. When cervical flexion deformity is present, excessive mechanical stress is applied to the cervicothoracic junction, which can accelerate ligament ossification and bony fusion at this site. When external force is applied in a state of only partial bony fusion, fractures readily occur at the cervicothoracic junction, where mobility remains.

3. Genetics

The genetic basis of cervicothoracic AS, as in systemic AS, centers on HLA-B27 (B*27:04 and B*27:05, the main subtypes in Koreans), IL23R, and ERAP1. Polymorphisms of the ANKH gene (ankyrin homolog, inorganic pyrophosphate transporter) and TNFRSF11B (osteoprotegerin) are associated with a tendency toward spinal ossification and may contribute to ossification of the cervicothoracic junction. Gene polymorphisms related to activation of the BMP-2 and BMP-4 signaling pathways affect the extent of ligament ossification. When osteoporosis genetic factors (VDR, COL1A1, LRP5) are present, the risk of fracture of the cervicothoracic junction increases. Studies of genes specific to CTJ AS are still limited.

4. General epidemiology

Separate epidemiologic studies of CTJ AS are lacking, and it is understood in the epidemiologic context of cervical and thoracic involvement in AS. Cervicothoracic junction involvement accompanies a considerable proportion of AS patients with cervical involvement. Because this site is difficult to evaluate on plain radiographs owing to radiographic overlap, CT must be used, which limits the collection of epidemiologic data. Fractures of the cervicothoracic junction are reported relatively less often than other vertebral fractures, but they actually tend to be underdiagnosed. Male sex, smoking, older age, and high disease activity are risk factors. Separate reports on the frequency of involvement of this site in Korean AS cohorts are rare.

5. Pathophysiology

The pathophysiology of CTJ AS appears as the systemic immune-ossification mechanism of AS superimposed on the particular biomechanical environment of this site. TNF-α/IL-17A-mediated inflammation of the entheses of the facet joints, disc-vertebral junctions, and anterior and posterior longitudinal ligaments forms syndesmophytes and ligament ossification through repeated cycles. When loss of cervical lordosis and exaggerated thoracic kyphosis are combined, flexion force is concentrated at the cervicothoracic junction, accelerating mechanical destruction and ossification repair at ligament attachment sites. In a state of reduced trabecular strength due to osteoporosis, concentration of flexion force at this site leads to insufficiency fracture (stress fracture) or traumatic fracture. Spinal cord compression can result from chronic stenosis due to syndesmophytes, acute injury due to fracture-dislocation, or epidural hematoma.

6. Symptoms

Symptoms of cervicothoracic AS are characterized by deep pain at the cervicothoracic junction, radiating pain in the neck and upper thoracic region, and upper limb nerve root symptoms (symptoms of the little finger and intrinsic hand muscles in the C8/T1 distribution). Symptoms of cervical and thoracic involvement appear mixed, accompanied by an inflammatory pattern of morning stiffness, worsening at rest, and relief with exercise. When the upper thoracic spinal cord is involved, abnormal lower limb reflexes, gait disturbance, and bladder dysfunction appear. A fracture of the cervicothoracic junction may present with sudden marked worsening of junctional pain and immediate neurological symptoms, especially after minor trauma. Respiratory dysfunction affects chest expansion capacity because chest wall fixation begins from this site.

7. Signs

On physical examination, local tenderness at the cervicothoracic junction and pain on percussion of the spinous process are checked. Chest expansion measurement reflects the degree of thoracic involvement, and chest expansion decreases when this site is involved. Upper limb neurological examination is performed (C8: little finger flexors, T1: intrinsic hand muscles; sensation: ulnar forearm-little finger) to distinguish cervical from thoracic junction radiculopathy patterns. Signs of myelopathy (Hoffman sign, lower limb hyperreflexia, Babinski) are also checked. Measurement of cervical lateral flexion and thoracic range of motion, which are included in the BASMI (Bath AS Metrology Index), is performed. On radiographs, syndesmophytes, discitis, and facet joint ankylosis at the C7-T1 boundary are evaluated.

8. Screening

For screening of the cervicothoracic junction, plain radiographs (cervical lateral, thoracic anteroposterior and lateral) are performed as the basis, but because radiographic overlap is severe at this site, CT is essential. MRI (T2/STIR covering the cervical-thoracic junction range) evaluates active inflammation, bone marrow edema, and spinal cord compression. Electromyography/nerve conduction studies confirm C8/T1 radiculopathy. Bone density measurement is included in the fracture risk assessment. Pulmonary function tests (FVC, TLC) evaluate whether chest wall restrictive respiratory impairment is present. Systemic disease activity is measured regularly with the ASDAS and BASDAI.

9. Diagnosis

A diagnosis of CTJ AS is made when, in a patient meeting AS criteria, radiographic or MRI abnormalities at this site (syndesmophytes, discitis, bony fusion, active bone marrow edema) are identified. CT is essential for evaluating the presence of fracture and structural instability. Differential diagnosis includes degenerative cervicothoracic spondylosis, DISH (diffuse idiopathic skeletal hyperostosis), and post-fracture pseudarthrosis. When neurological symptoms are present, the need for surgery is evaluated through neurosurgical consultation. Diagnosis code M45.3 is used when the lesion is localized to or predominantly located at the cervicothoracic junction.

10. Treatment

Drug treatment of cervicothoracic AS follows the systemic AS protocol (NSAIDs first line, TNF inhibitors/IL-17A inhibitors second line). In physical therapy, cervicothoracic junction stabilization exercises and posture correction (thoracic extension, scapular retraction) are important. When neurological symptoms are present or structural instability is confirmed, neurosurgical decompression and fusion are performed. For fractures of the cervicothoracic junction, conservative (thoracolumbar orthosis) or surgical management is decided according to the degree of neurological injury and instability. Under general anesthesia, airway management is planned in accordance with cervical spine evaluation. Concomitant osteoporosis treatment is essential for preventing fractures at this site.

11. Prognosis

The prognosis of AS with cervicothoracic junction involvement varies greatly depending on whether neurological complications are present. In stable involvement without neurological symptoms, function can be maintained with drug treatment and rehabilitation. Incomplete quadriplegia after a fracture at this site leaves residual disability in a considerable proportion. Early decompression surgery increases the likelihood of neurological recovery. Thorough control of systemic inflammation with TNF/IL-17 inhibitors can slow progressive ossification and functional decline. If chest wall restrictive respiratory impairment progresses, long-term respiratory function is affected, so regular monitoring of pulmonary function is needed.

12. Prevention

Prevention of cervicothoracic AS consists of early diagnosis and treatment of AS, smoking cessation, fall prevention, and regular exercise rehabilitation. Early detection of instability through follow-up whole-spine imaging including the cervicothoracic junction is important. Before spinal surgery or anesthesia involving this site, structural evaluation by CT and MRI must be performed. Posture correction education (avoiding hyperflexed postures, thoracic extension exercises) reduces the concentration of mechanical stress. Osteoporosis prevention and treatment are carried out in parallel to reduce the risk of fracture at this site. Management of cardiovascular risk factors also contributes to improved long-term prognosis.

13. References

1. van der Linden S, et al. Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheum. 1984;27(4):361-8.

2. Sieper J, et al. Ankylosing spondylitis: an overview. Ann Rheum Dis. 2002;61(Suppl 3):iii8-18.

3. Braun J, et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2011;70(6):896-904.

4. Poddubnyy D, et al. Rates and predictors of radiographic spinal progression in AS. Ann Rheum Dis. 2011;70(8):1369-74.

5. Baraliakos X, et al. MRI in AS: patterns of spinal changes. Rheumatology. 2017;56(3):421-32.

6. Reveille JD. Genetics of spondyloarthritis — beyond the MHC. Nat Rev Rheumatol. 2012;8(5):296-304.

7. Klingberg E, et al. Osteoporosis in ankylosing spondylitis — prevalence, risk factors and methods of assessment. Arthritis Res Ther. 2012;14(3):R108.

8. Ramiro S, et al. ASAS-EULAR recommendations for AS management: 2022 update. Ann Rheum Dis. 2023;82(1):19-34.

9. Kim TH, et al. Spondyloarthropathies in Korea: prevalence and clinical characteristics. J Korean Med Sci. 2021;36(12):e96.

10. Wanders AJ, et al. NSAIDs inhibit radiographic progression in AS. Arthritis Rheum. 2005;52(6):1756-65.